Credit Suisse is preparing to take leave of three members of its risk committee, including the number two on the board of directors Severin Schwan. The CEO of pharmaceutical giant Roche ‘has decided not to stand for re-election’.
Mr. Schwan will be imitated at the ordinary general meeting of April 29 by Kai Nargolwala and Juan Colombas, indicates the bank with the two veils on Monday.
The Chinese Shan Li will thus be the only survivor of a risk assessment committee that has been under strong pressure since the outbreak of the Greensill and Archegos debacles. The dedicated body has been chaired on an interim basis since last fall by Axel Lehmann, who has since been propelled to the presidency of the group following the hasty departure of the Portuguese Antonio Horta-Osorio, carried away by his indelicacy in respect of quarantine rules. .
If he was not on the front line of a revolt of shareholders expressed in the preamble to the 2021 general meeting, Severin Schwan had nevertheless been the subject of a call for non-re-election formulated by the Norwegian sovereign wealth fund , which then had nearly 3% in the capital of the Paradeplatz establishment.
Mirko Bianchi, Keyu Jin and Amanda Norton will be proposed to occupy the seats left vacant.
/ ATS
